Propan Biopharma’s $100M Ethereum-Focused Expansion: Blockchain as a Strategic Catalyst for Biopharma Innovation and Value Creat
-
最新报道：Propan Biopharma plans to invest $100 million in Ethereum over the next 12 months, aiming to diversify assets and leverage blockchain for biopharma innovation. The strategy includes using Ethereum’s smart contracts for tokenizing clinical trial data, supply chain tracking, and AI-driven R&D, while addressing concerns over resource allocation and crypto volatility.
下一篇
Investors Panic as Global Debt Storm Swells
- Japan's 30-year bond yield hit a record 3.255% amid global fiscal concerns, reflecting inv...
24小时热点
热点专题
407366